Artificial Heart Market Size, Competitors & Forecast to 2032

The artificial heart market is advancing rapidly, shaped by critical shifts in clinical demand, technology innovation, and multi-stakeholder collaboration. Senior executives navigating this sector require an integrated view of the evolving landscape to make informed strategic decisions.

Market Snapshot: Artificial Heart Market

The artificial heart market expanded from USD 3.14 billion in 2025 to USD 3.48 billion in 2026 and is projected to continue growing at a CAGR of 11.67%, reaching USD 6.81 billion by 2032. This growth is underpinned by technological innovation, an aging population with complex needs, and increasing demand for advanced treatments, making the sector a focal point for device manufacturers, healthcare providers, and payers.

Scope & Segmentation

Device Types: Total Artificial Heart and Ventricular Assist Devices address full cardiac replacement and varying degrees of circulatory support.
Clinical Applications: Bridge-to-transplant scenarios require short-term device reliability, while destination therapy emphasizes long-term durability and quality of life considerations.
Platform Technologies: Axial, centrifugal, electromagnetic, and pneumatic platforms offer differing hemocompatibility, power, and maintenance profiles.
Care Settings: Implant procedures largely occur in hospitals with acute monitoring, while specialty clinics and ambulatory centers handle device management, education, and patient optimization.
Patient Demographics: Distinctions between adult and pediatric applications drive unique device design, flow characteristics, and specialized clinical expertise.
Regional Focus: Americas, Europe Middle East & Africa, and Asia-Pacific each present distinct clinical infrastructure, regulatory dynamics, and commercialization priorities.

Key Takeaways

The shift from niche salvage therapy towards a central role in heart failure management is propelled by advances in material science, device miniaturization, and multidisciplinary care integration.
Digital integration and real-world data capture enable proactive monitoring, reducing post-implant complications and supporting outpatient care pathways.
Evolving regulatory frameworks recognize real-world evidence and adaptive trial designs, accelerating development and deployment cycles for new devices.
Strategic collaboration across manufacturers, suppliers, providers, and clinical partners is essential, as successful commercialization is increasingly linked to coordinated ecosystem efforts.
Regional differences in capabilities and payer models require tailored go-to-market and training strategies to optimize adoption and performance.

Tariff Impact & Procurement Dynamics

Mid-decade U.S. trade measures increased tariffs for specific medical components, influencing procurement budgets and prompting manufacturers to localize supply chains or diversify sourcing. These policy changes encouraged investments in regional manufacturing, strategic inventory management, and supplier diversification. Hospitals, facing higher costs, adapted procurement strategies—favoring bundled agreements and longer cycles—while some regions incentivized local capacity building to ensure access and system resilience. Device makers now balance agile localization with robust supply strategies to protect clinical momentum in a shifting economic landscape.

Methodology & Data Sources

This report uses a rigorous mixed-methods research approach, including structured interviews with clinicians, engineers, and procurement leaders. Supplementary sources span peer-reviewed publications, clinical trial registries, regulatory filings, and public policy analysis. Technical assessment and scenario analysis validated device performance, supply risks, and strategic responses. All insights were iteratively checked with industry stakeholders for clinical and commercial relevance.

Why This Report Matters

Delivers validated, up-to-date strategic intelligence tailored for executive decision-making in the artificial heart market.
Highlights actionable pathways for scaling innovation, navigating regulatory shifts, and optimizing regional rollouts.
Supports risk mitigation and value creation by integrating supply chain, clinical, and commercial best practices into comprehensive recommendations.

Conclusion

Success in the artificial heart market depends on flexible manufacturing, integrated clinical strategies, and payer alignment. Coordinated, evidence-driven execution will underpin sustainable growth and patient access in this critical sector.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Heart Market, by Type

8.1. Total Artificial Heart
8.2. Ventricular Assist Device
8.2.1. Biventricular Assist Device
8.2.2. Left Ventricular Assist Device
8.2.3. Right Ventricular Assist Device

9. Artificial Heart Market, by Application

9.1. Bridge To Transplant
9.2. Destination Therapy

10. Artificial Heart Market, by Technology

10.1. Axial
10.2. Centrifugal
10.3. Electromagnetic
10.4. Pneumatic

11. Artificial Heart Market, by End User

11.1. Ambulatory Surgical Centers
11.2. Hospitals
11.3. Specialty Clinics

12. Artificial Heart Market, by Patient Group

12.1. Adults
12.2. Pediatrics

13. Artificial Heart Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Artificial Heart Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Artificial Heart Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Artificial Heart Market
17. China Artificial Heart Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Abiomed, Inc.
18.7. Berlin Heart GmbH
18.8. BIOTRONIK SE & Co. KG
18.9. BiVACOR Inc.
18.10. Boston Scientific Corporation
18.11. Calon Cardio-Technology Ltd.
18.12. CARMAT SA
18.13. CorWave SA
18.14. CryoLife, Inc.
18.15. Edwards Lifesciences Corporation
18.16. Evaheart, Inc.
18.17. FineHeart SA
18.18. Getinge AB
18.19. Jarvik Heart, Inc.
18.20. Lepu Medical Technology Beijing Co., Ltd.
18.21. LivaNova PLC
18.22. Medtronic plc
18.23. MicroPort Scientific Corporation
18.24. RealHeart AB
18.25. ReliantHeart, Inc.
18.26. Siemens Healthineers
18.27. Sun Medical Technology R&D Co., Ltd
18.28. SynCardia Systems, LLC
18.29. Terumo Corporation

List of Figures

FIGURE 1. GLOBAL ARTIFICIAL HEART MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ARTIFICIAL HEART MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ARTIFICIAL HEART MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ARTIFICIAL HEART MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ARTIFICIAL HEART MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ARTIFICIAL HEART MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AXIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AXIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AXIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CENTRIFUGAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CENTRIFUGAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY CENTRIFUGAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ELECTROMAGNETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ELECTROMAGNETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ELECTROMAGNETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 85. EUROPE ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. EUROPE ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 88. EUROPE ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. EUROPE ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 99. AFRICA ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. AFRICA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 101. AFRICA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 102. AFRICA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. AFRICA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. AFRICA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. AFRICA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. ASEAN ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. ASEAN ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 116. ASEAN ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 117. ASEAN ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. ASEAN ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. ASEAN ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. ASEAN ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 121. GCC ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GCC ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 123. GCC ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 124. GCC ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. GCC ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. GCC ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. GCC ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 133. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 135. BRICS ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. BRICS ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 137. BRICS ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 138. BRICS ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. BRICS ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. BRICS ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. BRICS ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 142. G7 ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. G7 ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 144. G7 ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 145. G7 ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. G7 ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. G7 ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. G7 ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 149. NATO ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. NATO ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 151. NATO ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 152. NATO ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. NATO ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. NATO ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. NATO ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES ARTIFICIAL HEART MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 158. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 159. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)
TABLE 164. CHINA ARTIFICIAL HEART MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 165. CHINA ARTIFICIAL HEART MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 166. CHINA ARTIFICIAL HEART MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
TABLE 167. CHINA ARTIFICIAL HEART MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. CHINA ARTIFICIAL HEART MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. CHINA ARTIFICIAL HEART MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. CHINA ARTIFICIAL HEART MARKET SIZE, BY PATIENT GROUP, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Artificial Heart market report include:

Abbott Laboratories
Abiomed, Inc.
Berlin Heart GmbH
BIOTRONIK SE & Co. KG
BiVACOR Inc.
Boston Scientific Corporation
Calon Cardio-Technology Ltd.
CARMAT SA
CorWave SA
CryoLife, Inc.
Edwards Lifesciences Corporation
Evaheart, Inc.
FineHeart SA
Getinge AB
Jarvik Heart, Inc.
Lepu Medical Technology Beijing Co., Ltd.
LivaNova PLC
Medtronic plc
MicroPort Scientific Corporation
RealHeart AB
ReliantHeart, Inc.
Siemens Healthineers
Sun Medical Technology R&D Co., Ltd
SynCardia Systems, LLC
Terumo Corporation

Table Information

Report Attribute	Details
No. of Pages	198
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 3.48 Billion
Forecasted Market Value ( USD ) by 2032	$ 6.81 Billion
Compound Annual Growth Rate	11.6%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3480EUR$3,939USD£3,035GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3754EUR$4,249USD£3,273GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5088EUR$5,759USD£4,437GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6157EUR$6,969USD£5,369GBP

Artificial Heart Market - Global Forecast 2026-2032

Market Snapshot: Artificial Heart Market

Scope & Segmentation

Key Takeaways

Tariff Impact & Procurement Dynamics

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Artificial Heart Market

Scope & Segmentation

Key Takeaways

Tariff Impact & Procurement Dynamics

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Artificial Hearts - Global Strategic Business Report

Artificial Heart-Lung Machine Market Report by Type, and Region 2025-2033

Artificial Heart Annuloplasty Ring Market Report: Trends, Forecast and Competitive Analysis to 2031

Prosthetic Heart Valve & Artificial Heart Valve Market - Global Forecast 2025-2030

2025 Global Forecast for Artificial Heart Stent Market (2026-2031 Outlook)-High Tech Outlook Report

About the Market